Sector revisions Vanda Pharmaceuticals Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:01:34 2026-05-18 pm EDT			5-day change	1st Jan Change
6.075 ^USD	-3.26%		-4.15%	-31.86%

May. 07	Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026
May. 06	Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
VANDA PHARMACEUTICALS INC.				5
ARGENX SE				15
WUXI APPTEC CO., LTD.				17
INSMED INCORPORATED				20
BIONTECH SE				17
WUXI BIOLOGICS (CAYMAN) INC.				21
GENMAB A/S				15
AKESO, INC.				21
SUMMIT THERAPEUTICS INC.				13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
EXELIXIS, INC.				17
MADRIGAL PHARMACEUTICALS, INC.				14
ARROWHEAD PHARMACEUTICALS, INC.				12
CYTOKINETICS, INCORPORATED				19
PHARMAESSENTIA CORPORATION				6
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
IMMUNITYBIO, INC.				4
REMEGEN CO., LTD.				15
NUVALENT, INC.				18
VAXCYTE, INC.				9
Average				14
Weighted average by Cap.				15